Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
| Language | Translation |
|---|---|
English
|
Obesity |
French
|
Obésité |
| Level | Code | Title | |
|---|---|---|---|
| 1 | IV | Endocrine, nutritional and metabolic diseases | |
| 2 | E65-E68 | Obesity and other hyperalimentation | |
| 3 | E66 | Obesity |
| Code | Title | |
|---|---|---|
| E66.0 | Obesity due to excess calories | |
| E66.1 | Drug-induced obesity | |
| E66.2 | Extreme obesity with alveolar hypoventilation | |
| E66.8 | Other obesity | |
| E66.9 | Obesity, unspecified |
| Active Ingredient | Description | |
|---|---|---|
| Orlistat |
Orlistat is a potent, specific and long-acting inhibitor of gastrointestinal lipases. It exerts its therapeutic activity in the lumen of the stomach and small intestine by forming a covalent bond with the active serine site of the gastric and pancreatic lipases. The inactivated enzyme is thus unavailable to hydrolyse dietary fat, in the form of triglycerides, into absorbable free fatty acids and monoglycerides. |
|
| Sibutramine |
Subitramine is a potent inhibitor of monoamines (serotonin, dopamine, noradrenaline) reuptake for the treatmen of obesity. Sibutramine is metabolized to metabolites M1 and M2 which are more active toward the monoamine transporters. |
